This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
skiq [2021/01/08 17:09] trynke |
skiq [2025/02/05 14:49] (current) |
||
---|---|---|---|
Line 1: | Line 1: | ||
====== Skin Conditions (SKIQ) ====== | ====== Skin Conditions (SKIQ) ====== | ||
- | The Skin Conditions questionnaire is an [[additional assessments|additional assessment]] among adult [[cohort|Lifelines]] participants.\\ | + | The Skin Conditions questionnaire is an [[additional assessments|additional assessment]] among adult [[cohort|Lifelines]] participants. The digital questionnaire was developed at the initiative of the UMCG [[https://www.umcg.nl/NL/UMCG/Afdelingen/dermatologie/Wetenschappelijk_Onderzoek/Paginas/default.aspx|Department of Dermatology]] (NL). With the aim of the questionnaire being to gain more insight into [[https://en.wikipedia.org/wiki/Hidradenitis_suppurativa|hidradentitis supperativa]] and [[https://en.wikipedia.org/wiki/Dermatitis|eczema]] in the general population. |
- | The digital questionnaire was developed at the initiative of the UMCG [[https://www.umcg.nl/NL/UMCG/Afdelingen/dermatologie/Wetenschappelijk_Onderzoek/Paginas/default.aspx|Department of Dermatology]] (NL).\\ | + | |
- | The aim of the questionnaire was to gain more insight into [[https://en.wikipedia.org/wiki/Hidradenitis_suppurativa|hidradentitis supperativa]] and [[https://en.wikipedia.org/wiki/Dermatitis|eczema]] in the general population. | + | The collected SKIQ data is currently still under embargo. Please contact the Lifelines data managers at [[data@lifelines.nl]] for more information. |
+ | |||
+ | When the SKIQ data has been used in your research, you will have to include the following references: | ||
+ | * for publication on hand eczema: [[https://doi.10.2340/actadv.v101.432|Voorberg, A.N. et al. (2022) Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study, Acta Derm Venereol 102]] | ||
+ | * for publications on atopic dermatitis/eczema: [[https://doi.10.1111/jdv.17471|Zhang, J et al. (2021) Prevalence of adult atopic dermatitis in the general population, with a focus on moderate to severe disease: results from the Lifelines Cohort Study. Eur Acad Dermatol Venereol 35(11):e787-e790]] | ||
===== Protocol & response ===== | ===== Protocol & response ===== | ||
- | The digital questionnaire was sent out between february and may 2020.\\ | + | The digital questionnaire was sent out between February and May 2020.\\ |
- | ~136,000 adult Lifelines participants received the questionnaire, of which ~58,500 participants (43%) responded | + | ~136,000 adult Lifelines participants received the questionnaire, of which ~58,000 participants (43%) responded. |
===== Variables ===== | ===== Variables ===== | ||
- | The following questions were asked about skin disorders: | + | The questions included in the skin conditions questionnaire included items from the following subsections: |
+ | * [[Acne]] (8 items) | ||
+ | * [[Allergies]] (2 items) | ||
+ | * [[Eczema measure (POEM)]] (8 items) | ||
+ | * [[Familial diseases (other)]] (1 item) | ||
+ | * [[Medication]] (15 items) | ||
+ | * [[Occupational eczema (NOSQ)]] (52 items) | ||
+ | * [[Skin conditions]] (96 items) | ||
+ | * [[Treatment (general)]] (28 items) | ||
+ | |||
+ | ===== Publications using SKIQ data ===== | ||
+ | * Zhang, J et al. (2021) [[https://onlinelibrary.wiley.com/doi/10.1111/jdv.17471|Prevalence of adult atopic dermatitis in the general population, with a focus on moderate to severe disease: results from the Lifelines Cohort Study]]. Eur Acad Dermatol Venereol 35(11):e787-e790 | ||
+ | * * Zhang J et al. (2021) [[https://www.sciencedirect.com/science/article/pii/S2666328721001061?via%3Dihub|Impact of the COVID-19 pandemic on adults with moderate-to-severe atopic dermatitis in the Dutch general population]] JAAD Int 6:86-93 | ||
+ | * Zhang, J et al. (2022) [[https://academic.oup.com/ced/article/47/8/1523/6692927?login=true|Moderate-to-severe atopic dermatitis and lifestyle factors in the Dutch general population]]. Clin Exp Dermatol 47(8): 1523–1535 | ||
+ | * Voorberg, A.N. et al. (2022) [[https://onlinelibrary.wiley.com/doi/10.1111/cod.13804|Prevalence and Severity of Hand Eczema in the Dutch General Population: A Cross-sectional, Questionnaire Study within the Lifelines Cohort Study]], Acta Derm Venereol 102. | ||
+ | * Loman L. and Schuttelaar M.L.A. (2022) [[https://onlinelibrary.wiley.com/doi/10.1111/cod.14005|Hand eczema and lifestyle factors in the Dutch general population: Evidence for smoking, chronic stress, and obesity]]. Contact Dermatitis 86(2):80-88. | ||
+ | * Brands M.J. et al. (2022) [[https://onlinelibrary.wiley.com/doi/10.1111/cod.14066|Exposure and work-related factors in subjects with hand eczema: Data from a cross-sectional questionnaire within the Lifelines Cohort Study]]. Contact Dermatitis 86(6):493-506 | ||
+ | * Prens L.M. et al. (2022) [[https://academic.oup.com/bjd/article-lookup/doi/10.1111/bjd.20954|New insights in hidradenitis suppurativa from a population-based Dutch cohort: prevalence, smoking behaviour, socioeconomic status and comorbidities]] Br J Derm 186(5): 814–822 | ||
+ | * Zhang J et al. (2023) [[https://www.sciencedirect.com/science/article/pii/S2213219823000107?via%3Dihub|Limited health literacy and its associated health outcomes among adults with at least 2 atopic diseases]] J Allerg Clin Immunol 11(5): 1429-1438 | ||
+ | * Zhang J et al. (2023) [[https://medicaljournalssweden.se/actadv/article/view/9378|Beyond anxiety and depression: Loneliness and psychiatric disorders in adults with atopic dermatitis]] ActaDV 103, adv9378 | ||
+ | * van der Weijden DAY (2023) [[https://academic.oup.com/bjd/advance-article/doi/10.1093/bjd/ljad317/7259837?login=true|Hidradenitis suppurativa tarda: defining an understudied elderly population]] Br J Derm: ljad317 | ||
+ | * Brands M. J. et al. (2024) [[https://doi.org/10.1111/cod.14510|Hand eczema-related presenteeism and sickness absence: A cross-sectional population-based study]]. Contact Dermatitis 90(4):372-377 |